8 recruiting, 6 completed, 5 unknown, 4 active not recruiting. 7 Not applicable, 4 Phase 1, 4 Phase 2, 1 Phase 3, 1 Phase 4.
Follow Kidney Neoplasm: new trials by email Literature Review of Kidney Neoplasm trials Research Report on Kidney Neoplasm
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Hyperspectral Imaging in Robot-Assisted Partial Nephrectomy Kidney Neoplasm, Renal Mass up to 7cm | Recruiting | University of Leipzig | 60 | 2026-09-01 | 2026-09-03 | |
| Pre-NEOSHIFT-RCC: Neoadjuvant HIF-Inhibitor Immunotherapy in RCC Casdatifan, Zimberelimab - Renal Cell Carcinoma, Kidney Cancer | Phase 2 | Recruiting | Dana-Farber Cancer Institute | 32 | 2026-03-09 | 2026-03-20 |
| Clinical Trial Addressing the Best Surgical Approach for Partial Nephrectomy With Single Port Robotic System in the Management of Localized Renal Cell Carcinoma STANDARD FLANK APPROACH, Supine anterior retroperitoneal approach (SARA). - Kidney Neoplasm | Not applicable | Recruiting | Niguarda Hospital | 124 | 2025-10-10 | 2025-11-21 |
| Primary Tumor Ablation and Outcome in Metastatic Renal Cell Carcinoma Treated With Immunotherapy Combinations. Deferred Cytoreductive Nephrectomy + medical treatment, Radiotherapy + medical treatment, Medical therapy - Renal Cell Cancer, Kidney Neoplasm | Phase 4 | Recruiting | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 409 | 2025-06-15 | 2025-07-03 |
| Evaluation of 'RUS NE' in Robot-Assisted Partial Nephrectomy: Efficacy, Safety, and Stability RUS NE - Kidney Neoplasm, Nephrectomy | Not applicable | Enrolling by invitation | Hutom Corp | 80 | 2025-04-30 | 2025-09-16 |
| Systemic Treatment Alone Versus Systemic Treatment Plus Radiotherapy in Oligometastatic Renal Cell Carcinoma SBRT(Stereotatic Body Radiation Therapy) - Kidney Neoplasm | Phase 3 | Recruiting | Samsung Medical Center | 88 | 2024-04-16 | 2024-06-20 |
| Clinical Significance of Adherent Perinephric Fat in Patients Undergoing Partial Nephrectomy Renal Cell Carcinoma, Kidney Neoplasm | Active not recruiting | Centre of Postgraduate Medical Education | 200 | 2023-04-17 | 2025-06-27 | |
| Stereotactic Body Radiotherapy (SBRT) for Medically Inoperable Localised Renal Tumors (SABINA Trial) SBRT - Kidney Neoplasm, Renal Cancer | Active not recruiting | Consorci Sanitari de Terrassa | 60 | 2023-03-01 | 2024-05-10 | |
| Patient Reported Outcomes by Patients With Metastatic Renal Cell Carcinoma Electronic patient-reported outcomes regarding symptoms and health-related quality of life - Metastatic Renal Cell Carcinoma, Kidney Cancer | Not applicable | Unknown | Herlev and Gentofte Hospital | 174 | 2021-12-13 | 2021-11-26 |
| Impact of Chronic Renal Failure on Plasma Exposure of Kinase Inhibitors in Patients Treated for Metastatic Kidney Cancer blood sampling for ITK dosage - Kidney Neoplasm | Not applicable | Recruiting | Institut du Cancer de Montpellier - Val d'Aurelle | 60 | 2021-12-06 | 2025-02-12 |
| An MRI-Based Study of Intelligent Pathological Subtyping and Grading of Renal Tumors MRI-Based Artificial Intelligence Analysis - Renal Tumor, Kidney Neoplasm | Recruiting | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 900 | 2021-01-01 | 2026-08-04 | |
| German National Registry for NSS No intervention, observation only. - Kidney Neoplasm | Terminated | Association of Urologic Oncology (AUO) | 137 | 2020-12-15 | 2026-08-26 | |
| Hyper-Personalized Medicine Using Patient Derived Xenografts (PDXovo) for Metastatic Solid Tumors Kidney Neoplasm, Carcinoma, Renal Cell | Unknown | Sunnybrook Health Sciences Centre | 50 | 2020-12-01 | 2022-04-05 | |
| Individualized Treatment Strategy for Patients With Metastatic Non-clear Cell Renal Cell Carcinoma Medication (A specification is listed under each arm), Patient reported outcomes measurement - Metastatic Renal Cell Carcinoma, Kidney Neoplasm | Phase 2 | Unknown | Herlev and Gentofte Hospital | 30 | 2020-03-06 | 2020-11-25 |
| Hyperpolarized 13C Pyruvate MRI Scan in Predicting Tumor Aggressiveness in Patients With Renal Tumors Hyperpolarized Carbon C 13 Pyruvate, Magnetic Resonance Imaging, Hyperpolarized 13C,15N2-urea - Benign Kidney Neoplasm, Kidney Neoplasm | Phase 2 | Active not recruiting | Zhen Wang, MD | 54 | 2019-01-15 | 2026-02-23 |
| SPECT/CT for the Characterization of Renal Masses Computed Tomography, Questionnaire Administration, Single Photon Emission Computed Tomography - Kidney Neoplasm, Renal Mass | Active not recruiting | Jonsson Comprehensive Cancer Center | 102 | 2018-12-07 | 2026-03-13 | |
| CLamp vs Off Clamp Kidney During Partial Nephrectomy Clamp Robotic partial nephrectomy, Clampless Robotic partial nephrectomy - Nephrectomy, Kidney Neoplasm | Not applicable | Unknown | Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia | 200 | 2014-10-01 | 2016-01-05 |
| Body Warming in Improving Blood Flow and Oxygen Delivery to Tumors in Patients With Cancer Hyperthermia Treatment, Laboratory Biomarker Analysis - Adult Liver Carcinoma, Breast Carcinoma | Not applicable | Completed | Roswell Park Cancer Institute | 9 | 2013-10-04 | 2022-07-25 |
| [18F]Fluciclatide PET Imaging of Pazopanib Response 18F-Fluciclatide - Kidney Neoplasm | Phase 2 | Terminated | Asan Medical Center | 12 | 2013-09-01 | 2016-03-01 |
| A Clinical Study of the Living Renal Transplantation With Restored Kidneys Between Family Members Restored Kidney Transplant Between Family Members - Kidney Neoplasm, Kidney Stone | Not applicable | Unknown | Tokushukai Medical Group | 5 | 2009-07-01 | 2009-10-14 |
Showing 20 of 27. Sign in to see all of them.
Kidney Neoplasms (27) · Carcinoma, Renal Cell (13) · Breast Neoplasms (3) · Urologic Neoplasms (3) · Lung Neoplasms (2) · Neoplasm Metastasis (2) · Neoplasms (2) · Ovarian Neoplasms (2) · Renal Insufficiency (2) · Sarcoma (2) · Urogenital Neoplasms (2) · Angiolipoma (1) · Carcinoma, Hepatocellular (1) · Colonic Neoplasms (1) · Cysts (1)
Female Urogenital Diseases (27) · Female Urogenital Diseases and Pregnancy Complications (27) · Male Urogenital Diseases (27) · Neoplasms by Site (27) · Urogenital Diseases (27) · Urologic Diseases (27) · Kidney Diseases (26) · Neoplasms (25) · Urogenital Neoplasms (25) · Urologic Neoplasms (24) · Neoplasms by Histologic Type (16) · Adenocarcinoma (14) · Carcinoma (14) · Neoplasms, Glandular and Epithelial (14) · Pathological Conditions, Signs and Symptoms (5)
AH 111585 (1) · Blood Specimen Collection (1) · Diathermy (1) · Dosage Forms (1) · Magnetic Resonance Spectroscopy (1) · Nutrition Therapy (1) · Photons (1) · Radiotherapy (1) · Standard of Care (1) · Technetium Tc 99m Sestamibi (1) · X-Rays (1) · valspodar (1) · zimberelimab (1)
Herlev and Gentofte Hospital (2) · National Cancer Institute (NCI) (2) · Abramson Cancer Center at Penn Medicine (1) · Asan Medical Center (1) · Association of Urologic Oncology (AUO) (1) · Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia (1) · Cancer Institute and Hospital, Chinese Academy of Medical Sciences (1) · Centre of Postgraduate Medical Education (1) · Children's Oncology Group (1) · Consorci Sanitari de Terrassa (1) · Dana-Farber Cancer Institute (1) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS (1) · Hutom Corp (1) · Institut du Cancer de Montpellier - Val d'Aurelle (1) · Jonsson Comprehensive Cancer Center (1)
United States (10) · South Korea (4) · Italy (3) · Canada (2) · Denmark (2) · Germany (2) · Australia (1) · China (1) · France (1) · Israel (1) · Japan (1) · New Zealand (1) · Poland (1) · Puerto Rico (1) · Spain (1)
Ida Marie L Rasmussen, MD (2) · Alessandro Antonelli, Doctor (1) · Anurag Singh (1) · Brian Shuch (1) · Cheol Kwak, M.D.,Ph.D. (1) · Elizabeth A Mullen (1) · Elyse Watkins, BSc, PGDip (1) · Georg Bjarnason, MD (1) · Jin-Sook Ryu, MD. PhD. (1) · Joseph O'Donoghue, PhD (1) · Manuel Galdeano-Rubio, MD (1) · Mohamad E Allaf, MD, MBA (1) · Neeta Pandit-Taskar, MD (1) · Nina Harke, Dr. (1)
PMID 19375094, PMID 31342246, PMID 32267967, PMID 36107483, PMID 36506251, PMID 37933882, PMID 38245480, PMID 38396300, PMID 40262276, PMID 41707608, PMID 42433301, PMID 42657661
2019 (1), R01CA249909 (1), U10CA098543 (1), U10CA180886 (1), UG1CA189958 (1)